UCB has become the latest focus of inquiries by Chinese officials in a growing clampdown on drug pricing and marketing practices in the country.
中國官方加大了對藥品定價與營銷手段的整治力度,比利時制藥商優時比(UCB)成為最新調查目標。
? The Financial Times Ltd 2025 FT and 'Financial Times' are trademarks of The Financial Times Ltd.